Literature DB >> 1899905

Evidence of paired M2 muscarinic receptors.

L T Potter1, L A Ballesteros, L H Bichajian, C A Ferrendelli, A Fisher, H E Hanchett, R Zhang.   

Abstract

Binding assays involving various antagonists, including N-[3H] methylscopolamine, [3H]quinuclidinyl benzilate, AFDX-116, pirenzepine, and propylbenzilylcholine mustard, disclosed only a single population of M2 muscarinic receptors in membranes from the rat "brainstem" (medulla, pons, and colliculi). However, competition curves between N-[3H]methylscopolamine and various agonists, including oxotremorine, cis-dioxolane, and acetylethylcholine mustard, showed approximately equal numbers of guanine nucleotide-sensitive high affinity (H) sites and guanine nucleotide-insensitive low affinity (L) sites. This 50% H phenomenon persisted in different buffers, at different temperatures, after the number of receptors was halved (and, thus, the remaining receptor to guanine nucleotide-binding protein ratio was doubled), after membrane solubilization with digitonin, and when rabbit cardiac membranes were used instead of rat brainstem membranes. Preferential occupation of H sites with acetylethylcholine mustard, and of L sites with quinuclidinyl benzilate or either mustard, yielded residual free receptor populations showing predominantly L and H sites, respectively. Low concentrations of [3H]-oxotremorine-M labeled only H sites, and the Bmax for these sites was 49% of the Bmax found with [3H]quinuclidinyl benzilate plus guanine nucleotide. These and other results are most consistent with the idea that H and L receptor sites exist on separate but dimeric receptor molecules and with the hypothesis that only the H receptors cycle between high and low affinity, depending upon interactions between this receptor molecule and a guanine nucleotide-binding protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899905

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

Review 1.  Modelling the interdependence between the stoichiometry of receptor oligomerization and ligand binding for a coexisting dimer/tetramer receptor system.

Authors:  X Rovira; M Vivó; J Serra; D Roche; P G Strange; J Giraldo
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

2.  Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.

Authors:  Maren Grossmüller; Johannes Antony; Christian Tränkle; Ulrike Holzgrabe; Klaus Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-12-16       Impact factor: 3.000

3.  Functional rescue of a constitutively desensitized beta2AR through receptor dimerization.

Authors:  T E Hebert; T P Loisel; L Adam; N Ethier; S S Onge; M Bouvier
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

4.  Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathway.

Authors:  Lauren K Dobbs; Gregory P Mark
Journal:  Behav Brain Res       Date:  2011-09-17       Impact factor: 3.332

5.  The action of (+/-)L-660,863 [(+/-)3-(3-amino-1,2,4-oxadiazole-5-yl)-quinuclidine] at muscarinic receptor subtypes in vitro.

Authors:  R M Eglen; G C Harris; A P Ford; E H Wong; J R Pfister; R L Whiting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

6.  Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process.

Authors:  Brigitte Ilien; Nicole Glasser; Jean-Pierre Clamme; Pascal Didier; Etienne Piemont; Raja Chinnappan; Sandrine B Daval; Jean-Luc Galzi; Yves Mely
Journal:  J Biol Chem       Date:  2009-05-18       Impact factor: 5.157

7.  Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder.

Authors:  T Hirata; A Kakizuka; F Ushikubi; I Fuse; M Okuma; S Narumiya
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

8.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors.

Authors:  R Maggio; Z Vogel; J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.

Authors:  Lokesh Agrawal; Xihua Lu; Jin Qingwen; Zainab VanHorn-Ali; Ioan Vlad Nicolescu; David H McDermott; Philip M Murphy; Ghalib Alkhatib
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 10.  GPCR oligomers in pharmacology and signaling.

Authors:  Javier González-Maeso
Journal:  Mol Brain       Date:  2011-05-27       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.